7-4785561-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_014855.3(AP5Z1):​c.1009C>T​(p.Arg337Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,610,732 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R337Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000036 ( 1 hom. )

Consequence

AP5Z1
NM_014855.3 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.115

Publications

0 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3154042).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.1009C>T p.Arg337Trp missense_variant Exon 9 of 17 ENST00000649063.2 NP_055670.1 O43299-1
AP5Z1NM_001364858.1 linkc.541C>T p.Arg181Trp missense_variant Exon 8 of 16 NP_001351787.1
AP5Z1XM_047421098.1 linkc.673C>T p.Arg225Trp missense_variant Exon 7 of 15 XP_047277054.1
AP5Z1NR_157345.1 linkn.1102C>T non_coding_transcript_exon_variant Exon 9 of 17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.1009C>T p.Arg337Trp missense_variant Exon 9 of 17 NM_014855.3 ENSP00000497815.1 O43299-1

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000499
AC:
12
AN:
240438
AF XY:
0.0000685
show subpopulations
Gnomad AFR exome
AF:
0.000138
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000493
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000357
AC:
52
AN:
1458432
Hom.:
1
Cov.:
33
AF XY:
0.0000441
AC XY:
32
AN XY:
725358
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33438
American (AMR)
AF:
0.0000225
AC:
1
AN:
44374
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39646
South Asian (SAS)
AF:
0.000385
AC:
33
AN:
85722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52168
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5728
European-Non Finnish (NFE)
AF:
0.00000810
AC:
9
AN:
1111078
Other (OTH)
AF:
0.00
AC:
0
AN:
60248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152300
Hom.:
0
Cov.:
33
AF XY:
0.0000806
AC XY:
6
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41576
American (AMR)
AF:
0.0000654
AC:
1
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5156
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000257
Hom.:
0
Bravo
AF:
0.00000756
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000661
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 48 Uncertain:2
Jun 03, 2020
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jun 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 240932). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. This variant is present in population databases (rs367981328, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 337 of the AP5Z1 protein (p.Arg337Trp). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T;T
Eigen
Benign
0.013
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.17
N
LIST_S2
Uncertain
0.91
.;D
M_CAP
Benign
0.081
D
MetaRNN
Benign
0.32
T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Uncertain
2.7
M;M
PhyloP100
0.12
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.4
D;.
REVEL
Benign
0.19
Sift
Uncertain
0.0080
D;.
Sift4G
Uncertain
0.013
D;.
Polyphen
1.0
D;D
Vest4
0.59
MVP
0.35
ClinPred
0.82
D
GERP RS
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.36
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367981328; hg19: chr7-4825192; API